United States · FDA National Drug Code directory
Erzofri extended-release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72526-110_4c9a70a9-b1b5-b462-e063-6294a90adefd
- Product NDC
- 72526-110
- Form
- INJECTION
- Composition / generic term
- paliperidone palmitate
- Labeler
- Shandong Luye Pharmaceutical Co., Ltd.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241210
- Source listing expiry
- 20271231
Source-listed ingredients
- PALIPERIDONE PALMITATE — 351 mg/2.25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 KIT (72526-110-11) / 2.25 mL in 1 SYRINGE, GLASS · 72526-110-11
- 1 SYRINGE, GLASS in 1 KIT (72526-110-21) / 2.25 mL in 1 SYRINGE, GLASS · 72526-110-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →